Pediatric Pulmonary Vascular Disease

Chromosome 17q23.1-q23.2 deletion syndrome with severe pulmonary hypertension in neonates: two case reports and literature review

Xiaojiao Wu, Yanyan Cao, Jiancheng Jiao, Junchen Fang, Yudong Zhang, Li MaChildren’s Hospital of Hebei Province and Hebei Clinical Medicine Research Center for Children’s Health andDiseases.China BioMedical Central PediatricsBMC Pediatr 2026; DOI: 10.1186/s12887-026-06839-x AbstractBackground: Chromosome 17q23.1-q23.2 deletion syndrome is a rare genetic disorder characterized by various congenital defects, including microcephaly, heart and lung defects, limb abnormalities, […]

Chromosome 17q23.1-q23.2 deletion syndrome with severe pulmonary hypertension in neonates: two case reports and literature review Read More »

Non-invasive nitric oxide use for pulmonary hypertension and pulmonary vascular disease associated with bronchopulmonary dysplasia in preterm infants

Aastha Chandra, Danielle R. Rios, Daniel Dagle, Patrick J. McNamara, Adrianne R. BischoffUniversity of Iowa.United States Journal of PerinatologyJ Perinatol 2026; DOI: 10.1038/s41372-026-02687-w AbstractAbstract Not Available CategoryClass III. Pulmonary Hypertension Associated with Lung DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed

Non-invasive nitric oxide use for pulmonary hypertension and pulmonary vascular disease associated with bronchopulmonary dysplasia in preterm infants Read More »

From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review

Teresa Wong, Daniel Chan, Cherie Chua, Wenqi Cher, Selina Lim, Suresh Chandran, Fabian YapKK Women’s and Children’s Hospital. Duke NUS Medical School. Singapore Frontiers in PharmacologyFront Pharmacol 2026; 17:DOI: 10.3389/fphar.2026.1781424 AbstractPurpose: Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycaemia in neonates and infants (blood glucose <3.0 mmol/L in first 2-3 days of life; <3.5 mmol/L

From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review Read More »

Mutations in VCP cause Adams-Oliver syndrome with or without pulmonary hypertension

Anna Lehman, Sana Ahmed, Arezoo Mohajeri, Alison M. Berezuk, Dhiraj Mannar, Spencer Cholak, Katharine S. Tuttle, James T. Bennett, Jeanine Aparecida Magno, Mark Hannibal, Gordana Kovacevik, Vladimir Kuburovic, M.E. Suzanne Lewis, Oana Moldovan, Zoe Nelson, Salmo Raskin, Anthony M. Vandersteen, Jared C. Roach, Sriram Subramaniam, Millan S. PatelUniversity of British Columbia. University of Washington School

Mutations in VCP cause Adams-Oliver syndrome with or without pulmonary hypertension Read More »

Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges

Michael C. Tracy, Joseph M. Collaco, Gangaram Akangire, Nicolas A. Bamat, Manvi Bansai, Sara K. Dawson, Lystra P. Hayden, Winston M. Manimtim, Antonia P. Popova, Demet Toprak, Sharon A. McGrath-Morrow, Paul E. MooreStanford University. Johns Hopkins University. Children’s Mercy Hospital. University of Missouri Kansas City School of Medicine. Children’s Hospital of Philadelphia and University of

Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges Read More »

Hypertrophic Cardiomyopathy as a Key Feature of MRAS-Related Noonan Syndrome: New Case and Comprehensive Literature Review

Romain Martineau, Constance Wells, Florent Fuchs, Sophie Collardeau‐Frachon, Valentin Ruault, Sophie Colomb, Jean‐Michel Faure, Caroline Bartholmot, Marie Vincenti, Benjamin Ganne, Marjolaine WillemsUniversity Hospital of Montpellier and Montpellier University. CESP Center for Research in Epidemiology and Population Health. Hospices Civils de Lyon & Université Claude Bernard. France Prenatal DiagnosisPrenat Diagn 2026; DOI: 10.1002/pd.70134 AbstractNoonan syndrome (NS) is

Hypertrophic Cardiomyopathy as a Key Feature of MRAS-Related Noonan Syndrome: New Case and Comprehensive Literature Review Read More »

Case Report: Diffuse pulmonary lymphangiomatosis in a child

Ya-nan Zhang, Zhen Yuan, Jin-chen Du, Bin Liu, Fu Li, Shou-Cai Hu, Qing-Xin Li940th Hospital of Joint Logistics Support Force of Chinese People’s Liberation Army. Gansu University of Traditional Chinese Medicine.China Frontiers in PediatricsFront Pediatr 2026; 13: DOI: 10.3389/fped.2025.1591611 AbstractWe report a rare case of generalized lymphatic anomaly (GLA) in a 12-year-old male, presenting with intermittent

Case Report: Diffuse pulmonary lymphangiomatosis in a child Read More »

Common pulmonary vein atresia: a case report and treatment experience sharing of a newborn diagnosed with common pulmonary vein atresia after two operations

Kun Zhang, Shuguang Tao, Wei Gao, Jiangrong Gu, Linlin Wen, Yun FanHebei Children’s Hospital.China Frontiers in PediatricsFront Pediatr 2025; 13:DOI: 10.3389/fped.2025.1590620 AbstractCommon pulmonary vein atresia (CPVA) is a rare congenital heart disease characterized by the absence of functional connectivity between the pulmonary vein and any other heart cavity or systemic venous structure. A 13-h-old newborn (G3P3)

Common pulmonary vein atresia: a case report and treatment experience sharing of a newborn diagnosed with common pulmonary vein atresia after two operations Read More »

Outcomes and Patency Following Surgical Repair of Previously Stented Pulmonary Veins in Pediatric Patients

Allison Beckham Davila, Mariana Chavez, Kimberlee Gauvreau, Christina Ireland, Kathy J. Jenkins, Michael Farias, Eric N. Feins, Christopher W. BairdBoston Children’s Hospital and Harvard Medical School. Lurie Children’s Hospital of Chicago and Feinberg School of Medicine.United States Annals of Thoracic SurgeryAnn Thorac Surg 2026; DOI: 10.1016/j.athoracsur.2026.03.056 AbstractBackground: The study objective was to evaluate surgical outcomes of patients

Outcomes and Patency Following Surgical Repair of Previously Stented Pulmonary Veins in Pediatric Patients Read More »

Does inhaled nitric oxide treatment of pulmonary hypertension in extremely premature infants improve patient outcomes?

Tyler L. King, Patrick J. McNamara, Adrianne R. BischoffUniversity of Iowa.United States Journal of PerinatologyJ Perinatol 2026; DOI: 10.1038/s41372-026-02666-1 AbstractAbstract Not Available CategoryClass III. Pulmonary Hypertension Associated with Lung DiseaseMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Fresh (PHresh). Less than 1-2 years since publication Article Access

Does inhaled nitric oxide treatment of pulmonary hypertension in extremely premature infants improve patient outcomes? Read More »

Scroll to Top